Ram Chuttani - 02 May 2024 Form 4 Insider Report for ALLURION TECHNOLOGIES, INC. (ALUR)

Role
Chief Medical Officer
Signature
/s/ Jennifer Ausrotas, attorney-in-fact
Issuer symbol
ALUR
Transactions as of
02 May 2024
Net transactions value
$0
Form type
4
Filing time
06 May 2024, 20:22:53 UTC
Previous filing
01 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALUR Stock Option (Right to Buy) Award $0 +204,082 $0.000000 204,082 02 May 2024 Common Stock 204,082 $2.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vest on May 2, 2025, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.